Oscar Health (NYSE:OSCR) Shares Down 4.2%

Oscar Health, Inc. (NYSE:OSCR)’s share price fell 4.2% during trading on Monday . The company traded as low as $16.02 and last traded at $16.08. 899,065 shares traded hands during trading, a decline of 73% from the average session volume of 3,359,885 shares. The stock had previously closed at $16.78.

Analyst Ratings Changes

A number of research firms have recently commented on OSCR. Raymond James began coverage on Oscar Health in a report on Friday, March 22nd. They set an “outperform” rating and a $20.00 price target for the company. Wells Fargo & Company boosted their price target on Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a report on Wednesday, June 12th. Bank of America reissued a “neutral” rating and set a $21.00 price target (down previously from $25.00) on shares of Oscar Health in a report on Thursday, May 30th. Robert W. Baird began coverage on Oscar Health in a report on Thursday, May 30th. They set an “outperform” rating and a $28.00 price target for the company. Finally, Piper Sandler reissued an “overweight” rating and set a $25.00 price target on shares of Oscar Health in a report on Wednesday. Three equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.75.

Oscar Health Trading Up 4.1 %

The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.29. The firm has a 50-day moving average of $19.35 and a 200 day moving average of $15.83. The company has a market cap of $3.89 billion, a P/E ratio of -41.00 and a beta of 1.61.

Oscar Health (NYSE:OSCR) last announced its earnings results on Tuesday, May 7th. The company reported $0.62 EPS for the quarter, beating the consensus estimate of $0.28 by $0.34. Oscar Health had a negative return on equity of 5.77% and a negative net margin of 0.82%. The company had revenue of $2.14 billion for the quarter, compared to analyst estimates of $1.99 billion. During the same quarter in the prior year, the company earned ($0.18) EPS. The firm’s revenue for the quarter was up 45.8% compared to the same quarter last year. On average, analysts predict that Oscar Health, Inc. will post -0.05 earnings per share for the current fiscal year.

Insider Activity at Oscar Health

In related news, EVP Alessandrea C. Quane sold 25,550 shares of the company’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $19.46, for a total transaction of $497,203.00. Following the sale, the executive vice president now owns 237,347 shares in the company, valued at approximately $4,618,772.62. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, COO Steven Wolin sold 18,607 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $19.46, for a total transaction of $362,092.22. Following the transaction, the chief operating officer now directly owns 65,316 shares of the company’s stock, valued at approximately $1,271,049.36. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Alessandrea C. Quane sold 25,550 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $19.46, for a total value of $497,203.00. Following the transaction, the executive vice president now directly owns 237,347 shares in the company, valued at $4,618,772.62. The disclosure for this sale can be found here. Insiders have sold a total of 81,655 shares of company stock worth $1,589,006 in the last 90 days. Corporate insiders own 25.11% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Formation8 GP LLC purchased a new stake in shares of Oscar Health in the fourth quarter worth approximately $47,480,000. Price T Rowe Associates Inc. MD raised its stake in shares of Oscar Health by 153.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock worth $59,156,000 after purchasing an additional 2,409,160 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Oscar Health by 18.6% in the third quarter. Vanguard Group Inc. now owns 14,127,934 shares of the company’s stock worth $78,693,000 after purchasing an additional 2,211,743 shares during the last quarter. Iron Triangle Partners LP purchased a new stake in shares of Oscar Health in the fourth quarter worth approximately $18,781,000. Finally, First Light Asset Management LLC raised its stake in shares of Oscar Health by 117.3% in the first quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company’s stock worth $31,265,000 after purchasing an additional 1,134,919 shares during the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.